This compound is a modified nucleoside building block featuring a protected ribofuranose core with a fluorine substitution and a uracil base. It is primarily used as a synthetic intermediate in pharmaceutical research for the preparation of modified oligonucleotides.
Escopo do conteúdo: As informações desta página dizem respeito à identificação química e aos contextos de fornecimento industrial, pesquisa e produção. Não constituem alegação terapêutica, aconselhamento médico ou instruções de uso de medicamentos.
Adquirindo ou fornecendo este composto?
Publique seu inventário ou uma solicitação de compra
CAS 146954-74-7
5'-O-[bis(4-methoxyphenyl)phenylmethyl]uridine
protected nucleoside for oligonucleotide synthesis
5'-O-(Bis(4-methoxyphenyl)(phenyl)methyl)-2'-O-methyluridine
research compound for oligonucleotide synthesis
5'-O-DMT-2'-TBDMS-Uridine
protected uridine for oligonucleotide synthesis
Triethylamine 4-(((2R,3R,4R,5R)-2-((bis(4-methoxyphenyl)(phenyl)methoxy)methyl)-5-(2,4-dioxo-3,4-dihydropyrimidin-1(2H)-yl)-4-fluorotetrahydrofuran-3-yl)oxy)-4-oxobutanoate
Research reagent
3-[[(2R,3R,4R,5R)-2-[[bis(4-methoxyphenyl)-phenylmethoxy]methyl]-5-(2,4-dioxopyrimidin-1-yl)-4-fluorooxolan-3-yl]oxy-[di(propan-2-yl)amino]phosphanyl]oxypropanenitrile
modified nucleotide synthesis intermediate
Mirogabalin Impurities N75
pharmaceutical impurity reference standard
(2S)-2-({[(9H-fluoren-9-yl)methoxy]carbonyl}amino)-6-{[(prop-2-en-1-yloxy)carbonyl]amino}hexanoic acid
Protected amino acid for peptide synthesis
Dapagliflozin Impurity 9
Pharmaceutical impurity reference standard
1-[(2R,3R,4R,5R)-5-[[bis(4-methoxyphenyl)-phenylmethoxy]methyl]-3-fluoro-4-hydroxyoxolan-2-yl]pyrimidine-2,4-dione
CSSFZSSZXOCCJB-YULOIDQLSA-N
COC1=CC=C(C=C1)C(C2=CC=CC=C2)(C3=CC=C(C=C3)OC)OC[C@@H]4[C@H]([C@H]([C@@H](O4)N5C=CC(=O)NC5=O)F)O